title: Pharmacokinetic evaluation of indinavir and indinavir/ritonavir-containing antiretroviral regimens in a clinical setting.
authors.forename: Marta
authors.initials: M
authors.lastname: Boffito
authors.forename: Stefano
authors.initials: S
authors.lastname: Bonora
authors.forename: Riccardo
authors.initials: R
authors.lastname: Raiteri
authors.forename: Helen E
authors.initials: HE
authors.lastname: Reynolds
authors.forename: Patrick G
authors.initials: PG
authors.lastname: Hoggard
authors.forename: Alessandro
authors.initials: A
authors.lastname: Sinicco
authors.forename: David J
authors.initials: DJ
authors.lastname: Back
authors.forename: Giovanni
authors.initials: G
authors.lastname: Di Perri
mesh_terms: D000328:Adult; D019540:Area Under Curve; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D005260:Female; D017320:HIV Protease Inhibitors / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D006801:Humans; D019469:Indinavir / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D019438:Ritonavir / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use
chemical_list: D017320:HIV Protease Inhibitors; D019469:Indinavir; D019438:Ritonavir